AU4420101A - Use of a copolymer for producing a pharmaceutical product for the therapy of ulcerative colitis, and pharmaceutical product provided for the inventive use - Google Patents
Use of a copolymer for producing a pharmaceutical product for the therapy of ulcerative colitis, and pharmaceutical product provided for the inventive useInfo
- Publication number
- AU4420101A AU4420101A AU44201/01A AU4420101A AU4420101A AU 4420101 A AU4420101 A AU 4420101A AU 44201/01 A AU44201/01 A AU 44201/01A AU 4420101 A AU4420101 A AU 4420101A AU 4420101 A AU4420101 A AU 4420101A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical product
- therapy
- copolymer
- producing
- ulcerative colitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2000113030 DE10013030A1 (en) | 2000-03-17 | 2000-03-17 | Formulation for treating ulcerative colitis, comprising active agent, e.g. 5-aminosalicylic acid or prednisone, coated with acrylic copolymer to provide delayed release at high pH in the colon |
| DE10013030 | 2000-03-17 | ||
| PCT/EP2001/002677 WO2001068057A1 (en) | 2000-03-17 | 2001-03-09 | Use of a copolymer for producing a pharmaceutical product for the therapy of ulcerative colitis, and pharmaceutical product provided for the inventive use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4420101A true AU4420101A (en) | 2001-09-24 |
Family
ID=7635101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU44201/01A Withdrawn AU4420101A (en) | 2000-03-17 | 2001-03-09 | Use of a copolymer for producing a pharmaceutical product for the therapy of ulcerative colitis, and pharmaceutical product provided for the inventive use |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU4420101A (en) |
| DE (1) | DE10013030A1 (en) |
| WO (1) | WO2001068057A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
| US8282955B2 (en) | 2001-10-15 | 2012-10-09 | Ferring B.V. | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease |
| MXPA04010956A (en) * | 2003-01-30 | 2005-01-25 | Roehm Gmbh | Pharmaceutical dosage form and method for the production thereof. |
| CA2520197A1 (en) | 2003-04-23 | 2004-11-04 | Ferring B.V. | Sachet for a pharmaceutical composition |
| MXPA06009051A (en) * | 2004-02-10 | 2007-02-21 | Integrated Botan Technologies | Methods and compositions for the treatment of inflammation. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE9414066U1 (en) * | 1994-08-31 | 1994-11-03 | Röhm GmbH & Co. KG, 64293 Darmstadt | Coating and binding agents for pharmaceutical forms and pharmaceutical form produced therewith |
| IT1303753B1 (en) * | 1998-11-13 | 2001-02-23 | Ct Lab Farm Srl | ORAL ADMINISTRABLE PHARMACEUTICAL COMPOSITIONS CONTAINING A RESISTANT COATING BASED ON ACRYLIC POLYMERS. |
-
2000
- 2000-03-17 DE DE2000113030 patent/DE10013030A1/en not_active Withdrawn
-
2001
- 2001-03-09 AU AU44201/01A patent/AU4420101A/en not_active Withdrawn
- 2001-03-09 WO PCT/EP2001/002677 patent/WO2001068057A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE10013030A1 (en) | 2001-09-20 |
| WO2001068057A1 (en) | 2001-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001262318A1 (en) | Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament | |
| AU2001256184A1 (en) | 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases | |
| AU2002214996A1 (en) | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament | |
| AU3162001A (en) | Medicament, a method for its production and the use thereof | |
| IL153273A0 (en) | Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament | |
| AU2002234640A1 (en) | Xanthine derivative, production and use thereof as a medicament | |
| AU2002213977A1 (en) | Novel anticholinergics, method for the production thereof and use thereof as medicaments | |
| PL349425A1 (en) | Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament | |
| AU2001284021A1 (en) | Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof | |
| IL158289A (en) | Mercaptoacetylamide derivatives, a process for their preparation and their use as medicaments for the treatment of hypertension and chf | |
| AU2001262221A1 (en) | Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use | |
| HUP0301333A3 (en) | Pharmaceutical superdisintegrant, process for its preparation and its use | |
| HUP0203290A3 (en) | Indeno-, naphto-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments | |
| AU2001241056A1 (en) | Spiro compounds, process for preparing the same and use thereof as drugs | |
| AU3301700A (en) | (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy | |
| AU2001243515A1 (en) | Combination drug therapy | |
| AU4420101A (en) | Use of a copolymer for producing a pharmaceutical product for the therapy of ulcerative colitis, and pharmaceutical product provided for the inventive use | |
| AU2001260110A1 (en) | Novel LHRH-antagonists, Production and Use Thereof as Medicament | |
| AU2001262229A1 (en) | Cyclipostins, a method for their production and the use of the same | |
| AU2001284084A1 (en) | Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof | |
| AU2002229870A1 (en) | Mikanolide derivatives, their preparation and therapeutic uses | |
| AU2002218494A1 (en) | Medicinal compositions and process for producing the same | |
| AU2001241067A1 (en) | Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient | |
| AU2001282071A1 (en) | Multiparticulate pharmaceutical dosage form and a method for producing the same | |
| AU2401401A (en) | Migrastatin, process for producing the same and medicinal compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK13 | Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant |